Literature DB >> 4113563

Increased frequency of diabetes mellitus in patients with Huntington's chorea.

S Podolsky, N A Leopold, D S Sax.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4113563     DOI: 10.1016/s0140-6736(72)91092-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  54 in total

Review 1.  Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

Review 2.  Energy dysfunction in Huntington's disease: insights from PGC-1α, AMPK, and CKB.

Authors:  Tz-Chuen Ju; Yow-Sien Lin; Yijuang Chern
Journal:  Cell Mol Life Sci       Date:  2012-05-25       Impact factor: 9.261

Review 3.  Polyglutamine toxicity in non-neuronal cells.

Authors:  Jennifer W Bradford; Shihua Li; Xiao-Jiang Li
Journal:  Cell Res       Date:  2010-03-16       Impact factor: 25.617

Review 4.  Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

Authors:  Kawser Akter; Emily A Lanza; Stephen A Martin; Natalie Myronyuk; Melanie Rua; Robert B Raffa
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

5.  Huntingtin-interacting protein 14 is a type 1 diabetes candidate protein regulating insulin secretion and beta-cell apoptosis.

Authors:  Lukas Adrian Berchtold; Zenia Marian Størling; Fernanda Ortis; Kasper Lage; Claus Bang-Berthelsen; Regine Bergholdt; Jacob Hald; Caroline Anna Brorsson; Decio Laks Eizirik; Flemming Pociot; Søren Brunak; Joachim Størling
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-24       Impact factor: 11.205

Review 6.  Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body.

Authors:  Bronwen Martin; Erin Golden; Alex Keselman; Matthew Stone; Mark P Mattson; Josephine M Egan; Stuart Maudsley
Journal:  Histol Histopathol       Date:  2008-02       Impact factor: 2.303

7.  A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease.

Authors:  Andrew M Tidball; Miles R Bryan; Michael A Uhouse; Kevin K Kumar; Asad A Aboud; Jack E Feist; Kevin C Ess; M Diana Neely; Michael Aschner; Aaron B Bowman
Journal:  Hum Mol Genet       Date:  2014-12-08       Impact factor: 6.150

8.  Selective expression of Huntingtin-associated protein 1 in {beta}-cells of the rat pancreatic islets.

Authors:  Min Liao; Xingxing Chen; Jinhong Han; Shiming Yang; Ting Peng; He Li
Journal:  J Histochem Cytochem       Date:  2009-11-09       Impact factor: 2.479

9.  Regulation of L-type Ca2+ Channel Activity and Insulin Secretion by Huntingtin-associated Protein 1.

Authors:  Jing-Ying Pan; Shijin Yuan; Tao Yu; Cong-Lin Su; Xiao-Long Liu; Jun He; He Li
Journal:  J Biol Chem       Date:  2016-09-13       Impact factor: 5.157

Review 10.  Neuropathology and therapeutic intervention in spinal and bulbar muscular atrophy.

Authors:  Haruhiko Banno; Masahisa Katsuno; Keisuke Suzuki; Fumiaki Tanaka; Gen Sobue
Journal:  Int J Mol Sci       Date:  2009-03-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.